Bayer seeks wider use for eye drug Eylea in Europe

German drugmaker Bayer said it filed for marketing approval in Europe for the use of eye drug Eylea as a treatment of diabetic macular oedema.

Cancer drug ruling: It is triumph of human values, says Natco Director

The IPAB ruling in favour of the Natco Pharma against Bayer has reignited the debate over innovation versus access in the health sector.

Bayer to challenge India`s ruling allowing cheaper cancer drug copy

India`s decision to allow the production of a cheaper generic copy of a patented cancer drug will be challenged by German drug maker Bayer.

`India patent ruling may open door for cheaper HIV drugs`

India`s move to strip German drugmaker Bayer of its exclusive rights to a cancer drug has set a precedent that could extend to other treatments.

`India patent ruling may open door for cheaper HIV drugs`

India`s move to strip German drugmaker Bayer of its exclusive rights to a cancer drug has set a precedent that could extend to other treatments.